GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Role of FGFR1 signaling in distinct cell lineages in prostate cancer progresssion

$742,690
David M Spencer · Baylor College Of Medicine · U01 · FY2010 · CA

COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT

$742,500
Barry P Sleckman · University Of Alabama At Birmingham · P30 · FY2020 · CA

Modelling the dynamics of spontaneous clonal hematopoiesis in pet dogs during cancer therapy

$742,391
Cheryl A London · Tufts University Boston · R01 · FY2025 · CA

Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy

$742,234
Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL

Engineering personalized micro-tumor ecosystems

$742,092
Shiladitya Sengupta · Brigham And Women'S Hospital · U01 · FY2020 · CA

Hydrogel microparticle technology for high-throughout screening of chimeric antigen receptor-T cells based on single cell effector function

$741,926
Joseph De Rutte · Partillion Bioscience Corporation · R44 · FY2024 · GM

Role of inflammation, innate resistance, and immunity in carcinogenesis

$741,872
Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer

$741,840
David P Carbone · Ohio State University · R01 · FY2025 · CA

The role of the tumor biofilm in determining tissue tropism

$741,815
Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Protease/PAR2/TRPV4 Axis and Oral Cancer Pain

$741,363
Brian L Schmidt · New York University · R01 · FY2019 · DE

Vermont Breast Cancer Molecular Characterization Laboratory

$741,335
Janet L Stein · University Of Vermont & St Agric College · U01 · FY2017 · CA

Imaging tumor and T cell responses to metabolic and immune modulation therapy

$741,049
Taha Merghoub · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA

PROJECT 2: Development and Refinement of Predictive Models for Designing Immunotherapy Combination Treatments

$740,955
Vesteinn Thorsson · Institute For Systems Biology · U54 · FY2024 · CA

DNA-based Immune Phenotyping in HNSCC for Biomarkers of Response to Immunotherapy

$740,622
Karl T Kelsey · Brown University · R01 · FY2021 · CA

Modeling HIV CAR-T cell trafficking and persistence in Non-Human Primates

$740,614
Hans-Peter Kiem · University Of Pennsylvania · U19 · FY2022 · AI

Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress

$740,577
Christopher D Willey · University Of Alabama At Birmingham · U01 · FY2018 · CA

Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes

$740,135
Wei-Jun Qian · Battelle Pacific Northwest Laboratories · R01 · FY2021 · DK

Spatial Multi-omic Analysis of HIV-infected Cell Reservoirs in the Tumor Microenvironment

$740,000
Eli Boritz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

Integrative bioinformatics and functional characterization of oncogenic driver aberrations in cancer

$739,554
Gordon B. Mills · Oregon Health & Science University · U01 · FY2018 · CA

Integrative bioinformatics and functional characterization of oncogenic driver aberrations in cancer

$739,551
Gordon B. Mills · University Of Tx Md Anderson Can Ctr · U01 · FY2017 · CA

PROJECT 2: Development and Refinement of Predictive Models for Designing Immunotherapy Combination Treatments

$739,484
Vesteinn Thorsson · Institute For Systems Biology · U54 · FY2025 · CA

Personalized vaccine for patients with AML

$739,429
David E Avigan · Beth Israel Deaconess Medical Center · R01 · FY2017 · CA

NextGen - CRI

$738,441
Catherine Mary Bollard · Children'S Research Institute · OT2 · FY2023 · CA

Systems biology of intratumoral heterogeneity in glioblastoma

$738,422
Nitin S Baliga · Institute For Systems Biology · R01 · FY2025 · CA

Immune determinants of progression from Oral Epithelial Dysplasia to Oral Squamous Cell Carcinoma by precision multiplexed imaging

$738,039
Matthew Spitzer · University Of California, San Francisco · R01 · FY2025 · DE